Learn More
R&D Systems™ Human IL-21, Carrier-Free Recombinant Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Brand: R&D Systems™ 8879-IL-050/CF
Description
The Recombinant Human IL-21 Protein is derived from E. coli. The Recombinant Human IL-21 Protein has been validated for the following applications: Bioactivity.Specifications
| Q9HBE4 | |
| Observed M.W.: 17kDa, reducing conditions, Theoretical M.W.: 15kDa | |
| E. coli-derived human IL-21 protein Gln25-Ser155,with a N-terminal Met | |
| <0.10 EU per 1μg of the protein by the LAL method. | |
| IL-21 | |
| Measured in a cell proliferation assay using N1186 human T cells. Parrish-Novak, J. et al. (2000) Nature 408:57. The ED50 for this effect is typically 2-12ng/mL. | |
| Yes |
| 59067 | |
| 50μg | |
| 12 months from date of receipt, ≤ -20° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, ≤ -20° C under sterile conditions after reconstitution. | |
| IL21, IL-21Za11interleukin-21, interleukin 21, interleukin-21 isoform | |
| IL21 | |
| Unconjugated |
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.